Analyzing lung cancer risks in patients with impaired pulmonary function through characterization of gut microbiome and metabolites/Experiment 1/Signature 2

EditHistoryDelete

Flag for review

Your review change was submitted

Reviewed Marked as Reviewed by Svetlana up on 2024-6-20

Curated date: 2024/03/21

Curator: Omojokunoluwatomisin

Revision editor(s): WikiWorks, Scholastica, Omojokunoluwatomisin, Tosin

Source: figure 2b

Description: Differential taxa at the genus level analyzed by linear discriminant analysis (LDA) scores in lung cancer patients (C) versus benign diseases patients(N)

Abundance in Group 1: decreased abundance in Lung cancer (L group)

NCBI	Quality Control	Links
Blautia
Carnobacterium
Coprococcus
Fusicatenibacter
Kurthia
Lachnoanaerobaculum
Propionibacterium
Ruminococcus gauvreauii
Subdoligranulum
unclassified Atopobiaceae
Lachnospiraceae ND3007Lachnospiraceae ND3007
Clostridium sp. CAG:352

Revision editor(s): WikiWorks, Scholastica, Omojokunoluwatomisin, Tosin